Effects of Critical Patient-centered Skin Care Protocol

Sponsor
Istanbul Bilgi University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05948306
Collaborator
Istanbul University - Cerrahpasa (IUC) (Other)
140
2
8.7

Study Details

Study Description

Brief Summary

Many critical diseases can damage skin and tissue integrity due to natural immobility, hemodynamic instability, poor tissue perfusion, use of medical devices and many other internal and external factors. Skin damage frequently seen in intensive care units; It can be listed as skin tears and secondary cutaneous infections, especially pressure injuries (PI) and incontinence-associated dermatitis (IAD). In the DecubICU's study, which has the largest sample number ever, published in 2021, the prevalence of pressure ulcers and related factors in 1117 intensive care units from 90 different countries were evaluated; Pressure ulcers were detected in 6747 of 13,254 patients hospitalized in the ICU, and 57% of these wounds were reported to be associated with the intensive care unit.

In addition to pressure injuries, another skin problem that has also been focused on in nursing science in the last 10 years; incontinence-associated dermatitis. IAD, which develops on the skin exposed to urine and faeces, is not only a skin damage that needs to be examined on its own, but also paves the way for the development of pressure sores and can also progress together with pressure injuries. The study which was published in 2018, examined 109 intensive care patients, while the incidence of IAD was determined as 23.6%, while in 2019 another study in which 351 patients were included for 52 weeks, annual prevalence of IAD ranged from 17% and weekly incidences ranged from 0-70%. The findings of three different studies conducted in the intensive care unit are that IAD developed in 6% of 112 patients, 26.2% of 145 patients, and 65.4% of 266 patients, respectively. However, despite the limited literature, the high prevalence rates and the strong relationship between pressure injuries and incontinence associated dermatitis point to the necessity of evaluating these two skin injuries together.

Each existing skin injury reduces the quality of life by causing pain and pain to the individual, and also increases hospitalizations and infection rates, placing a financial burden on the health system and causing loss of workforce. For all these reasons, skin problems are considered as a quality indicator in hospitals and the primary responsibility for maintaining skin integrity is attributed to nurses. Guidelines published by EPUAP, National Pressure Injury Advisory Panel and Pan Pacific Pressure Injury Alliance (PPPIA) in 2019 in the prevention of pressure injuries in intensive care units play a key role in determining nurses' attempts to preserve skin and tissue integrity. In the prevention of incontinence-related dermatitis, the best practices guide published by Dimitri Beckmann in 2015 should be integrated into clinics.

Furthermore, the person-centered approach in skin care has been considered as a concept that should be focused on by the authors in recent years, and in a systematic review published in 2020, clinical applications of the person-centered care approach in wound care were suggested by considering the current evidence. However, the resources in which prevention strategies are focused on individual-centered care are very limited. Therefore, in this study, it was aimed to develop a critical patient-centered skin care protocol and to examine the effects of this protocol on the barrier functions of the skin.

HYPOTHESES AND DETAILED AIMS ARE BELOW.

The primary aim of the study is to examine the effect of critical patient centered skin care on the barrier function of the skin. The hypotheses for the primary purpose of this study are as follows:

H0: Application of critical patient-centered skin care protocol has no effect on skin barrier function (skin temperature, transepidermal water loss, skin pH, and secondary infection).

H1: Application of critical patient-centered skin care protocol has an effect on the barrier function of the skin (skin temperature, transepidermal water loss, skin pH, and secondary infection).

The secondary aim of the study is to examine the effects critical patient-centered skin care on the incidence and development time of incontinence-associated dermatitis and pressure injuries. In this direction, the hypotheses for the secondary purpose of this study are as follows:

H0: Application of critical patient-centered skin care protocol has no effect on the incidence of incontinence associated dermatitis and the incidence of pressure injury and their development times.

H1: Application of critical patient-centered skin care protocol has an effect on the incidence of incontinence associated dermatitis and the incidence of pressure injury and their development times.

Condition or Disease Intervention/Treatment Phase
  • Other: Critical Patient-Centered Skin Care Protocol
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
140 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This study was planned as a randomized controlled trial including experimental and control groups.This study was planned as a randomized controlled trial including experimental and control groups.
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Effects of Critical Patient-centered Skin Care Protocol on Barrier Functions of Skin
Anticipated Study Start Date :
Jul 10, 2023
Anticipated Primary Completion Date :
Oct 30, 2023
Anticipated Study Completion Date :
Mar 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Patient-centered skin care group

A patient-centered skin care protocol developed according to the Stetler Model will be applied to the experimental group.

Other: Critical Patient-Centered Skin Care Protocol
A patient-centered skin care protocol prepared by the researchers in accordance with the Stetler Model will be applied to the experimental group. Sub-titles of this protocol; evaluation of risk factors, examination of the skin from head to toe, skin hygiene, examining the effects of critical illness on the skin, mobilization and re-positioning, incontinence management, maintaining nutrition, and using a support surface. For each sub-heading, application items regarding patient demands and suggestions will be added.

No Intervention: Routine skin care group

The routine skin care of the ICU will be applied to the control group during the study.

Outcome Measures

Primary Outcome Measures

  1. Change of transepidermal water loss [This parameter will be measured through study completion for every day, an average of 10 for each patient.]

    This outcome includes transepidermal water loss. It will be assessed by researcher with VapoMeter.

  2. Change of skin pH [This parameter will be measured through study completion for every day, an average of 10 for each patient.]

    This outcome includes skin pH changing. It will be assessed by researcher with pHmeter.

  3. Change of skin temperature [This parameter will be measured through study completion for every day, an average of 10 for each patient.]

    This outcome includes skin temperature changing. It will be assessed by researcher with pHmeter.

Secondary Outcome Measures

  1. Incidence of pressure injuries [Patients included during the study will be followed for at least 10 days or through the hospitalization]

    Pressure injuries will be assessed according to the EPUAP stage system

  2. Incidence of incontinence associated dermatitis. [Patients included during the study will be followed for at least 10 days or through the hospitalization]

    Incontinence associated dermatitis will be assessed according to the GLOBIAD stage system

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Taking care in the ICU for 24 hours as a stable patient,

  • Glasgow coma scale to be at least 10 points,

  • Having at least one of the urinary/fecal/mixed incontinence types,

  • Being treated in the intensive care unit for at least 7 days,

  • Being over 18 years old

Exclusion Criteria:
  • Being after cardiopulmonary resuscitation (post CPR),

  • Brain death has occurred,

  • Having had multiple trauma,

  • Being diagnosed with allergic asthma

  • Having any skin health problem before ICU admission

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Istanbul Bilgi University
  • Istanbul University - Cerrahpasa (IUC)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
TUĞBA YENİ, Lecturer, Istanbul Bilgi University
ClinicalTrials.gov Identifier:
NCT05948306
Other Study ID Numbers:
  • 2022/81
First Posted:
Jul 17, 2023
Last Update Posted:
Jul 18, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by TUĞBA YENİ, Lecturer, Istanbul Bilgi University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 18, 2023